Zobrazeno 1 - 10
of 323
pro vyhledávání: '"meningococcal serogroup a"'
Autor:
Gary S. Marshall, Victoria Abbing-Karahagopian, Helen S. Marshall, Silvia Cenci, James H. Conway, Emilia Occhipinti, Rafik Bekkat-Berkani, Angelika Banzhoff, Woo-Yun Sohn
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 530-544 (2023)
Introduction Neisseria meningitidis causes invasive meningococcal disease and, globally, significant morbidity, with serogroup B (MenB) being the most common cause of endemic disease and outbreaks in several regions. Extensive use of the four-compone
Externí odkaz:
https://doaj.org/article/5daed63073d345389ee6f909c76924d7
Autor:
Elizabeth R. Packnett, Nicole M. Zimmerman, Patricia Novy, Laura C. Morgan, Nnenna Chime, Parinaz Ghaswalla
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
In the United States (US), meningococcal serogroup B (MenB) vaccination has been recommended for 16–23-year-olds (preferably 16–18 years) based on shared clinical decision-making since 2015. MenB vaccine coverage (≥1 dose) by age 17 years has b
Externí odkaz:
https://doaj.org/article/6c42ad777e9845508d6a5b8ab61677ae
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 3, Pp 919-926 (2021)
Meningococcal serogroups A and C cause significant numbers of cases in China. The Sanofi Pasteur meningococcal polysaccharide A + C vaccine (Men-AC) was licensed in China in 1995. Immunogenicity and safety of a single dose of Men-AC against a similar
Externí odkaz:
https://doaj.org/article/8db6f1d5c0f64e97bd33f6de30094c29
Autor:
Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum, Philipp Oster
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
MenACYW-TT (MenQuadfi®) is a quadrivalent meningococcal tetanus toxoid conjugate vaccine licensed in Europe for use in individuals ≥12 months. This study assessed whether serogroup C immune responses with MenACYW-TT were at least non-inferior, or
Externí odkaz:
https://doaj.org/article/f8fdf994f438443daff54e11407cc4ab
Autor:
Pierre Muhoza, Monica P. Shah, Hongjiang Gao, Kwame Amponsa-Achiano, Pamela Quaye, William Opare, Charlotte Okae, Philip-Neri Aboyinga, Kwadwo L. Opare, Melissa T. Wardle, Aaron S. Wallace
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1515 (2023)
Background: Understanding the drivers of coverage for vaccines offered in the second year of life (2YL) is a critical focus area for Ghana’s life course approach to vaccination. This study characterizes the predictors of vaccine receipt for 2YL vac
Externí odkaz:
https://doaj.org/article/8adc61ad342c44d38cc65473007f502c
Autor:
Sarah J. Tozer, Helen V. Smith, David M. Whiley, Ray Borrow, Giuseppe Boccadifuoco, Duccio Medini, Davide Serruto, Marzia Monica Giuliani, Maria Stella, Rosita De Paola, Alessandro Muzzi, Mariagrazia Pizza, Theo P. Sloots, Michael D. Nissen
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 9, Pp 3230-3238 (2021)
Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Ne
Externí odkaz:
https://doaj.org/article/6a72f64bde4941cd97e2199d0797ffb5
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 7, Pp 2205-2215 (2021)
Many countries are replacing meningococcal serogroup C (MenC) conjugate vaccines (MCCV) with quadrivalent conjugate (MenACWY) vaccines, such as MenACWY-TT (Nimenrix®). This review examined eight studies comparing MenC immune responses induced by Men
Externí odkaz:
https://doaj.org/article/7c00dfce82de454db382e432fa972b53
Publikováno v:
International Journal of Infectious Diseases, Vol 104, Iss , Pp 189-197 (2021)
Objective: This narrative review considers the epidemiology of invasive meningococcal disease (IMD) in North Africa and the adequacy of current preventive measures to provide guidance for future vaccination strategies. Methods: Literature searches we
Externí odkaz:
https://doaj.org/article/0796b31262f2452595a93c4990ad5347
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Meningococcal serogroup B (MenB) is the most common cause of invasive meningococcal disease (IMD) in the United States. The US Advisory Committee on Immunization Practices (ACIP) recommends vaccination of healthy adolescents again
Externí odkaz:
https://doaj.org/article/0b70cc719347440da03104a614de8bd4
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract Background The recent emergence of strains belonging to the meningococcal serogroup W (MenW) sequence type-11 clonal complex and descending from the South American sub-lineage (MenW:cc11/SA) has caused significant shifts in the epidemiology
Externí odkaz:
https://doaj.org/article/20a3a8340c1b4574afb5aaac3190a558